IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
26.92
-0.57 (-2.07%)
At close: Oct 7, 2025, 4:00 PM EDT
26.92
0.00 (0.00%)
After-hours: Oct 7, 2025, 4:20 PM EDT
IDEAYA Biosciences Market Cap
IDEAYA Biosciences has a market cap or net worth of $2.36 billion as of October 7, 2025. Its market cap has decreased by -20.84% in one year.
Market Cap
2.36B
Enterprise Value
1.39B
1-Year Change
-20.84%
Ranking
Category
Stock Price
$26.92
Market Cap Chart
Since May 23, 2019, IDEAYA Biosciences's market cap has increased from $215.57M to $2.36B, an increase of 994.49%. That is a compound annual growth rate of 45.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 2.41B | 8.46% |
| Dec 31, 2024 | 2.22B | -3.15% |
| Dec 29, 2023 | 2.29B | 162.34% |
| Dec 30, 2022 | 874.22M | -3.92% |
| Dec 31, 2021 | 909.90M | 123.69% |
| Dec 31, 2020 | 406.77M | 168.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |